Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

Condition:   Uterine Cervical Cancer Intervention:   Drug: SG001 Sponsor:   CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials